Digitisation | May 12, 2026
HealthQuad invests in AI-powered LifeSigns
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
Healthcare leaders, policymakers, hospitals, and patient advocates discuss AI-driven healthcare, digital transformation, quality of life in cancer care
The six-part webinar series aims to enhance awareness, diagnosis, and management of autoimmune diseases
The ultrasound-based AI imaging platform is designed to support rapid fracture detection and soft tissue injury assessment in emergency care settings
The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio
Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector
Offers a non-surgical treatment option for tricuspid regurgitation, a commonly underdiagnosed heart valve disorder linked to heart failure
The clinical study in France evaluated the safety and feasibility of Robocath’s robotic-assisted coronary intervention platform across complex cardiac cases.
The hospital chain reported strong growth driven by its Gurugram facility, international patient inflow, and operational efficiencies
Clinical guidelines and expert consensus recommend 1.2–1.5 g/kg/day protein intake during therapy to help preserve muscle mass
Subscribe To Our Newsletter & Stay Updated
